Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug543 | Best Message + Augmented Message or Implementation Strategy Wiki | 1.00 |
| drug544 | Best Message Alone Wiki | 1.00 |
| drug1561 | Focused/Targeted Message Wiki | 1.00 |
Navigate: Correlations HPO
There is one clinical trial.
The primary goal of this project is to identify the best messaging and implementation strategies to maximize SARS-CoV-2 testing for children with intellectual and developmental disabilities (IDD) and their teachers to help ensure a safe school environment. Additionally, we will understand nationally the perceptions of COVID-19 and identify facilitators and barriers to help with the adoption of testing in other parts of the US and the necessary strategies to address other mitigation strategies including vaccination.
Description: Ratio of the total number test per the number of weeks of analysis (eg. Phase 1 20 weeks)
Measure: Adoption of weekly testing by each participant Time: 52 weeksDescription: The acceptability of each strategy will be assessed with a validated survey of the families and staff prior to the intervention and at the conclusion of the intervention being utilized.
Measure: Acceptability of Messaging/Implementation Strategy Time: 1 yearDescription: The feasibility of each strategy will be assessed with a validated survey of the families and staff prior to the intervention and at the conclusion of the intervention being utilized.
Measure: Feasibility of Messaging/Implementation Strategy Time: 1 yearDescription: The appropriate of each strategy will be assessed with a validated survey of the families and staff prior to the intervention and at the conclusion of the intervention being utilized.
Measure: Appropriateness of Messaging/Implementation Strategy Time: 1 yearDescription: The total number of days missed by students and staff at the special schools during the 52 weeks of the study will be obtained.
Measure: Number of missed school days by students or work days by staff Time: 52 weeksDescription: The percentage of students and staff positive for SARS-CoV-2 virus will be determined
Measure: Students and staff positive SARS-CoV-2 virus Time: 52 weeksDescription: Number of possible SARS-CoV-2 transmission events occurring between students and staff within the school setting.
Measure: School-based SARS-CoV-2 transmission events Time: 52 weeksAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports